65,437 trials
Hyperglycemia
Primary: Differences in Glycemic Control as Measured by Time Reach Glycemic Control for Each Treatment Group. — 5; 10.1; 7.7 Time to reach glycemic control in hours — p=<0.05
Autistic Disorder · Behavioral Symptoms
Primary: Number of Participants With Serious Adverse Events (SAEs), Treatment-Emergent Adverse Events (AEs), Deaths, AEs Leading to Discontinuation, Extra Pyramidal Syndrome…
Acute Otitis Media
Primary: Area Under the Curve From Time Zero to 72 Hours (AUC72Hours) — 12173.023; 7950.949 ng*hr/ml
Hypertension
Primary: Change From Baseline in Mean Systolic Blood Pressure (SBP) After 12 Weeks of Randomized Treatment as Measured by Omron Device. — -0.1; -22.3 mm Hg — p=<0.0001
Bipolar Disorder
Primary: Change From Baseline to Week 3 in Young Mania Rating Scale (YMRS) — -10.19; -10.95; -9.47 scores on scale — p=0.1077
Breast Cancer
Primary: Patients Event-free at 12 Months (Where Event = Death (From Any Cause), Disseminated Tumour Cells (DTC) Positive at 12 Months or Clinical Disease Recurrence) — 6; 7…
Haemophilus Influenzae Type b · Neisseria Meningitidis
Primary: Number of Subjects With Anti-polyribosylribitol Phosphate (Anti-PRP) Antibody Concentration Greater Than or Equal to 0.15 Micrograms Per Milliliter (µg/mL) — 139; 141…
Controlled Ovarian Stimulation
Primary: The Amount of International Units (IU) of Recombinant Follicle Stimulating Hormone (recFSH) Needed in a Controlled Ovarian Stimulation (COS) Cycle up to the First Day…
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1) at Day 337 — 0.119; 0.018 Litres — p=<0.0001
Prostatic Hypertrophy, Benign
Primary: Baseline-adjusted Least Squared (LS) Means of Peak Urinary Flow (Qmax) at 3 Months After Surgery or Last Observation Carried Forward (LOCF) — 8.3; 9.4; 23.1; 25.7…
Small Cell Lung Carcinoma
Primary: Overall Survival (OS) for the Full Analysis Population (FAP) — 10.2177; 9.6591 months — p=0.0556
Narcolepsy
Primary: Change From Baseline in Maintenance of Wakefullness Test (MWT) Score at 12 Weeks — 2.6; 1.3; -1.9; 1.9 Minutes — p=0.0024
Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Intraocular Pressure (IOP) — -1.5; -0.7; -1.0; -0.2 mm Hg
Therapeutic Equivalency
Primary: Maximum Plasma Concentration (Cmax) — 1,165.92; 1,202.28 ng/mL
Postmenopause · Hypertension · Pre-Hypertension
Primary: Change From Baseline to Week 8 in Mean 24-hour SBP From the Ambulatory Blood Pressure Monitoring (ABPM) Measurements in Full Analysis Set (FAS) Population — -1.03…